Loading clinical trials...
Loading clinical trials...
SON4PEM Study: Sonlicromanol in Post-COVID: A Randomized, Double-blind, Placebo-controlled, Phase II Trial
Conditions
Interventions
Sonlicromanol
Placebo
Locations
1
Netherlands
Amsterdam University Medical Center, Location Academic Medical Center (AMC)
Amsterdam, North Holland, Netherlands
Start Date
April 1, 2026
Primary Completion Date
February 1, 2027
Completion Date
March 1, 2027
Last Updated
April 13, 2026
Lead Sponsor
Michele van Vugt
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions